Venture-Backed Startups

0 investors

0 investors

2 investors

1 investor

AviusULD manufactures and supplies unit load devices (ULDs) — air cargo containers and pallets — for airlines, ULD management companies, and MROs worldwide. Part of CCE Group, the company operates manufacturing and service facilities in Bangkok, Alkmaar, and Auburn, serving the APAC, EMEA, and Americas markets.

1 investor

AVIV is a digital real estate technology company operating marketplaces and valuation services for property transactions across Europe and Israel. The group owns leading regional real estate marketplaces and classifieds platforms, along with valuation and realtor enablement services.

1 investor

0 investors

Aviv Clinics operates physician-led clinics offering a personalized hyperbaric oxygen therapy program (the Aviv Medical Program) aimed at improving cognitive and physical performance for people who are aging or recovering from chronic medical conditions. Its UHMS-accredited clinic is located in central Florida and its protocol is based on peer-reviewed hyperbaric medicine research.

1 investor

Aviva is a financial institution in Mexico that provides personal loans to individuals and small business owners through video calls conducted at kiosks, with a focus on straightforward lending without extensive paperwork.

6 investors

Aviva Natural Supplements is a contract manufacturer of nutraceuticals, dietary supplements and vitamins, offering custom and stock formulas along with production and packaging. It provides turnkey manufacturing of capsules, tablets, powder blends and liquids for supplement brands worldwide.

1 investor

Avive develops automated external defibrillators (AEDs) and cardiac emergency response systems designed to improve outcomes for sudden cardiac arrest. The company serves communities, first responders, and institutions seeking accessible, affordable life-saving equipment.

5 investors

Avive operates a licensed private mental health hospital offering inpatient psychiatric care with private single bedrooms, circadian lighting, and multidisciplinary clinical teams. It treats adults with conditions such as depression, anxiety, trauma, addiction, and mood disorders, including veterans and first responders, primarily serving patients in Australia (Melbourne, Victoria, Brisbane, and surrounding regions).

1 investor

AvivoBio develops enzyme-based technology to convert blood and donor organs into a universal type O, removing ABO blood-type incompatibility as a barrier to transfusions and organ transplants. Its work targets clinicians and the transplant field, aiming to match donations by medical need rather than blood type.

1 investor

Avivomed is a medical device company developing minimally invasive neuromodulation therapies for patients with obstructive sleep apnea. Based in the Minneapolis area, it targets mild-to-moderate OSA patients who cannot tolerate CPAP.

3 investors

Aviwell develops microbiota-based feed solutions to improve animal health and growth for livestock and fish producers in the agri-food industry. It uses a hybrid AI/ML discovery platform combining in-silico and in-vivo approaches, drawing on research into the gut-brain microbiota axis, to create natural direct fed microbials.

1 investor

Aviz Networks develops networking software for open, disaggregated network infrastructure, with a focus on AI-driven operations and data center networking. Its team spans engineering, product, and customer success functions.

2 investors

Avizia provides a digital care platform integrating technology, services, and devices to support care delivery across in-person, virtual, and automated settings for providers, payers, and patients. The company operates in the healthcare technology sector, serving clinicians and healthcare organizations.

2 investors

0 investors

Avlino builds optimization software, including its 3-O (Objective Oriented Operating) Systems, that aligns operational plans and decisions with business goals across the container supply chain. It serves maritime logistics operators such as terminals, applying data-driven optimization to reduce fragmentation, delays, and inefficiencies.

1 investor

AVM Biotechnology develops AVM0703, a proprietary concentrated dexamethasone formulation designed to trigger the release and production of specialized immune cells (gamma delta and invariant TCR+ bispecific T lymphocytes and NK T-like cells) as a treatment approach for various diseases. The company operates in the biotechnology and immunotherapy space, with a therapeutic candidate in pre-clinical and clinical stages.

0 investors

MyWay MSK offers a patent-pending musculoskeletal care management program that uses mobile device technology to deliver self-guided therapy recommendations and real-time expert counseling for early-onset MSK pain. It targets individuals, employers, and health plan sponsors, integrating with existing healthcare plans to reduce unnecessary procedures and costs.

1 investor

Avo develops a clinical AI platform designed for healthcare providers to support evidence-based clinical decision-making while reducing clinician burnout. The platform helps clinicians access medical knowledge and adhere to clinical pathways within their electronic health records.

4 investors

Avo is a DeFi platform that enables capital allocation through AI trading agents and curated smart indexes, allowing users to allocate funds based on narratives and strategies on Solana. The platform serves cryptocurrency traders and investors seeking autonomous portfolio management and agent-executed trades.

1 investor

Avo is a SaaS analytics governance platform that helps product managers, developers, and data scientists plan, track, and govern product analytics. The platform enables organizations to make data-driven decisions quickly while maintaining data quality and preventing customer churn.

6 investors